AVANT DIAGNOSTICS

Avant Diagnostics, Inc. is a medical technology company based on the completion of the human genome-sequencing project. Avant Diagnostics are developing specialized tests that are cutting edge in medical testing and our OvaDxยฎ Pre-Symptomatic Ovarian Cancer Screening Test is a leading breakthrough in commercializing these tests.
AVANT DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2008-10-16
Address:
Scottsdale, Arizona, United States
Country:
United States
Website Url:
http://www.avantdiagnostics.com
Total Employee:
1+
Status:
Active
Contact:
(480)478-6660
Email Addresses:
[email protected]
Total Funding:
1.28 M USD
Technology used in webpage:
Domain Not Resolving Pound Sterling Japanese Yen Amazon California Region
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-05-12 | Amarantus Diagnostics | Amarantus Diagnostics acquired by Avant Diagnostics | N/A |
2016-05-12 | Theranostics Health | Theranostics Health acquired by Avant Diagnostics | N/A |
Official Site Inspections
http://www.avantdiagnostics.com
- Host name: 104.21.77.212
- IP address: 104.21.77.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Avant Diagnostics"
Avant Diagnostics - Crunchbase Company Profile & Funding
Avant Diagnostics, Inc. is a medical technology company based on the completion of the human genome-sequencing project. Avant Diagnostics are developing specialized tests that are โฆSee details»
Avant Diagnostics, Inc. | LinkedIn
Avant Diagnostics, Inc. (OTCQB: AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company is seeking FDA approval of a โฆSee details»
Avant Diagnostics - Craft
Avant Diagnostics is a medical diagnostic technology company that specializes in large panel biomarker screening. It develops phosphoproteomic technologies for measuring the activation โฆSee details»
Avant Diagnostics Company Profile | Management and Employees โฆ
[email protected]: Avant Diagnostics Top Competitors. Company Employees Revenue Top technologies; GeneNews Ltd. n/a: $4.9 M: Ambergen Inc. 16: $3.3 M: Provista โฆSee details»
Avant Diagnostics - Overview, News & Similar companies
May 8, 2019 A copy of the update can also be found on the Companyโs website at www.avantdiagnostics.com. May 8, 2019. www.globenewswire.com . AVANT DIAGNOSTICS โฆSee details»
Avant Diagnostics Inc - Company Profile and News
Company profile page for Avant Diagnostics Inc including stock price, company news, executives, board members, and contact informationSee details»
Avant Diagnostics - Products, Competitors, Financials, Employees ...
Headquarters Location. 8561 East Anderson Drive Suite 104. Scottsdale, Arizona, 85255, United States. 480-478-6660See details»
M&A Summary, Ownership, and Business Overview - Mergr
Dec 31, 2014 www.avantdiagnostics.com. Profile Investors (2) M&A Activity (2) M&A Connections (1) Analytics Avant Diagnostics, Inc. is a medical technology company based on โฆSee details»
Avant Diagnostics, Inc. Corporate Update - GlobeNewswire
Washington, DC, May 08, 2019 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. hereby provides the following corporate update to the Companyโs shareholders. A...See details»
Avant Diagnostics Company Profile 2024: Valuation, Investors ...
Avant Diagnostics General Information Description. Avant Diagnostics was a developer of molecular profiling software, based in Washington D.C., United States. The company used to โฆSee details»
Avant Diagnostics, Inc. Announces Launch of New Corporate โฆ
Dec 15, 2015 Avant Diagnostics, Inc. , "Avant", unveiled its new website on December 12, 2015. The site, avantdiagnostics.com, incorporates numerous features to make browsing a more โฆSee details»
Avant Diagnostics - VentureRadar
Avant Diagnostics VentureRadar profile. Find out more about Avant Diagnostics, Diagnostics.See details»
AVANT DIAGNOSTICS ADDS TWO ESTEEMED, INTERNATIONALLY โฆ
Oncology Solutions Organization, Product Marketing for the Molecular Imaging business, and had managed $1.6 billion in innovative growth marketing strategies. In addition, Andy has worked โฆSee details»
Avant Diagnostics CEO and Key Executive Team | Craft.co
Avant Diagnostics's Chairman of the Board is Jeffrey Busch. Other executives include Mick Ruxin, President, Chief Executive Officer and Director; Trevor McCartney, Senior Director, Business โฆSee details»
OncBioMune acquires assets of Avant Diagnostics
Jun 8, 2020 OncBioMune Pharmaceuticals Inc. acquired all assets of privately held Avant Diagnostics Inc.. Washington, D.C.-based Avant develops screening tests, which include the โฆSee details»
Avant Diagnostics Announces Restructuring and Private Placement โฆ
May 30, 2018 /CNW/ -- Avant Diagnostics, Inc. ("Avant") (OTC: AVDX), an oncology-focused healthcare data-generating solutions company commercializing the proprietary...See details»
Avant Diagnostics Inc. Commences OvaDx(R) Ovarian Cancer Test ...
Sep 24, 2015 The validation study and 510(k) trial will be conducted in a double-blinded environment supervised by DOCRO, Inc., an independent clinical research organization. The โฆSee details»
What is Avant Diagnostics? Company Culture, Mission, Values
See what employees say it's like to work at Avant Diagnostics. Salaries, reviews, and more - all posted by employees working at Avant Diagnostics.See details»
Avant Diagnostics Acquires Exclusive Option to License Genetic โฆ
Jul 12, 2017 GAITHERSBURG, Maryland, July 12, 2017 /PRNewswire/ --. Genetic Health Solution platform helps chronic disease patient management; Patient-centric biomarker-based โฆSee details»
Avant Diagnostics Announces Restructuring and Private Placement
WASHINGTON, May 30, 2018 /PRNewswire/ -- Avant Diagnostics, Inc. ("Avant") (OTC: AVDX), an oncology-focused healthcare data-generating solutions company commercializing the โฆSee details»